HRTX — Heron Therapeutics Share News
0.000.00%
Last trade - 00:00- $57.49m
- $158.52m
- $154.90m
U.S. RESEARCH ROUNDUP-Huntington Bancshares, Kodiak Sciences, Prokidney
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX
U.S. STOCKS ON THE MOVE-PaxMedica, Heron, Belite Bio
Brief: Heron Therapeutics Announces $30 Mln Private Placement Financing
Brief: Heron Therapeutics Announces Cost Reduction Plan And Restructuring
Heron Therapeutics up on cost reduction plan, job cuts
Brief: Heron Therapeutics Announces Appointment Of Ira Duarte As Chief Financial Officer
Heron Therapeutics hits record low on bigger-than-expected Q1 loss
Heron Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Heron Therapeutics Announces Financial Results For The Three Months Ended March 31, 2023
Brief: Heron Therapeutics posts Q1 EPS USD -0.27
Heron Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Heron Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Booking Holdings, Incyte, Wingstop
U.S. RESEARCH ROUNDUP- General Mills, McDonald's, Wells Fargo & Co
Heron Therapeutics gains on quarterly revenue beat
Heron Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Heron Therapeutics Announces Results For Three Months Ended December 31, 2022
Heron Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview